| ²é¿´: 734 | »Ø¸´: 1 | |||
ziecoeͳæ (СÓÐÃûÆø)
|
[½»Á÷]
תȾTLR4¼ì²â˫ӫ¹âËØÃ¸£¬Ï¸°û±³¾°Ì«¸ßÊǺͽ⣿£¿
|
|
ϸ°û293FT ÖÊÁ££º TLR4100ng MD-2 100ng pBX-II luc NF-¦ÊB 50ng pRL-TK 0.5ng Invitrogen Lipo2000Ö¬ÖÊÌå תÕâ4¸öÖÊÁ££¬×ªÈ¾6Сʱ»»Òº£¬È»ºóµÈ24СʱÓÃpromegaÊÔ¼ÁºÐÁѽâ¼ì²â£¬ 1.ֻתȾÁ½¸öÓ«¹âÖÊÁ£µÄ¿×£¬±³¾°±ÈÖµ0.5 2.תȾTLR4+MD-2+Á½¸öÓ«¹âÖÊÁ££¬¾ÓÈ»±ÈÖµÓÐ44±¶ 3.תȾTLR4+MD-2+Á½¸öÓ«¹âÖÊÁ££¬5ng/ml LPS´Ì¼¤£¬¾ÓÈ»»¹ÊÇ44±¶ ˵Ã÷תȾTLR4/MD-2×Ô¼º¾ÍÒѾÔڻÁË£¿µ«ÊÇͬÅú×öµÄתȾTLR2¾ÍûÓÐÎÊÌ⣬ֻÓÐTLR4ÊÇÕâÑù×Ó£¬ÕâÊÇʲôÎÊÌ⣿ÓÐûÓÐÕ½ÓÑÅöµ½¹ý£¿ ²»Í¬Åú´ÎÅàÑø»ù£¬²»Í¬Åú´ÎѪÇ壬²»Í¬Åú´ÎÌáµÄÈ¥ÄÚ¶¾ËØÖÊÁ££¬¶¼ÊÔÁË£¬»¹ÊÇÕâÑù×Ó£¿ ÊÇÈ¥ÄÚ¶¾ËØÌáÖÊÁ£Ê±È¥µÄ²»ºÃ£¬ÓвÐÁôÂ𣿵«ÊÇÎÒ6СʱÒѾȫ»»ÒºÁË »¹ÊÇÓÐÖ§ÔÌåÎÛȾϸ°ûÁË£¿ÎÒÃǵ½ÊÇûÓÐ×ö¹ý³ýÖ§ÔÌå²Ù×÷£¬µ«ÊÇÃ²ËÆÖ§ÔÌå²»»î»¯TLR4£¬Ö»»î»¯TLR2 |
» ²ÂÄãϲ»¶
µ°°×Öʼì²â£º¾«×¼·ÖÎö£¬½âËøÉúÎï·Ö×ÓµÄÃÜÂë
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑé֮СÊóʵÑ飺ÑϽ÷Éè¼Æ£¬½âÎöÉúÃü»úÖÆµÄÖØÒªÔØÌå
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ57È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®ÖØ½ðÊô¼ì²â£º¾«×¼É¸²é£¬ÊØ»¤½¡¿µÓë»·¾³µÄ·ÀÏß
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÍܲâÖØ½ðÊôÎÒ±³¹øÈýǧ¡±
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÊóÌÓÈý´ÎÎÒ·¢ÈýƪSCI¡±
ÒѾÓÐ0È˻ظ´
ÄÉÃ×Á£¶È·ÖÎö
ÒѾÓÐ3È˻ظ´
ÁÖ¿ÆÔºÁÖ»¯ËùÕÐÊÕ²ÄÁÏÓ뻯¹¤×¨ÒµË¶Ê¿£¬×ø±êÄϾ©
ÒѾÓÐ0È˻ظ´
Áôѧ--²©Ê¿ÕÐÉú
ÒѾÓÐ15È˻ظ´
»¯Ñ§¹¤³Ì£¬±¾211£¬Çóµ÷¼Á£¬abÇø²»ÏÞ
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
2014Äê¶ÈÕã½Ê¡×ÔÈ»¿ÆÑ§»ù½ðÄâ×ÊÖúÏîÄ¿Çåµ¥
ÒѾÓÐ14È˻ظ´
ziecoe
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 86
- Ìû×Ó: 51
- ÔÚÏß: 21.3Сʱ
- ³æºÅ: 802028
- ×¢²á: 2009-07-01
- רҵ: Ñ×Ö¢¡¢¸ÐȾÓëÃâÒß
2Â¥2015-05-02 02:36:21














»Ø¸´´ËÂ¥